EZH2 was found not to be methylated in CMML or in healthy controls according to the results of the methylation arrays with β values <0.3, indicating that the methylation of the EZH2 promoter region itself was not responsible for the differences in methylation in CMML. Here, EZH2 is linked to chronic myelomonocytic leukemia.